GPCR
Income statement / Annual
Last year (2025), Structure Therapeutics Inc's total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2025, Structure Therapeutics Inc's net income was -$141.20 M.
See Structure Therapeutics Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$3.90 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$20.03 K
|
| Gross Profit |
-$3.90 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$20.03 K
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$225.26 M
|
$108.81 M
|
$70.10 M
|
$36.19 M
|
$29.11 M
|
$12.39 M
|
| General & Administrative Expenses |
$61.55 M
|
$49.41 M
|
$32.67 M
|
$16.37 M
|
$8.59 M
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$61.55 M
|
$49.41 M
|
$32.67 M
|
$16.37 M
|
$8.59 M
|
$3.53 M
|
| Other Expenses |
-$3.14 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$283.67 M
|
$158.23 M
|
$102.78 M
|
$52.56 M
|
$37.70 M
|
$15.91 M
|
| Cost And Expenses |
$287.57 M
|
$158.23 M
|
$102.78 M
|
$52.56 M
|
$37.70 M
|
$15.91 M
|
| Interest Income |
$35.97 M
|
$36.03 M
|
$13.38 M
|
$1.26 M
|
$122.00
|
$168.29 K
|
| Interest Expense |
$0.00
|
$0.00
|
$13.39 M
|
$0.00
|
$122.16 K
|
$0.00
|
| Depreciation & Amortization |
$3.90 M
|
$992.00 K
|
$295.00 K
|
$277.00 K
|
$72.00 K
|
$20.03 K
|
| EBITDA |
-$136.79 M |
-$157.24 M |
-$102.48 M |
-$52.28 M |
-$37.62 M |
-$15.75 M |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$146.51 M
|
$36.01 M
|
$13.39 M
|
$1.26 M
|
-$122.00 K
|
$168.29 K
|
| Income Before Tax |
-$140.69 M
|
-$122.22 M
|
-$89.38 M
|
-$51.30 M
|
-$37.82 M
|
-$15.77 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$515.00 K
|
$310.00 K
|
$236.00 K
|
$17.00 K
|
$231.00 K
|
$138.24 K
|
| Net Income |
-$141.20 M
|
-$122.53 M
|
-$89.62 M
|
-$51.32 M
|
-$40.01 M
|
-$15.90 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-2.4 |
-2.34 |
-2.43 |
-1.44 |
-1.2 |
-0.45 |
| EPS Diluted |
-2.4 |
-2.34 |
-2.43 |
-1.44 |
-1.2 |
-0.45 |
| Weighted Average Shares Out |
$59.20 M
|
$52.64 M
|
$36.73 M
|
$36.59 M
|
$36.59 M
|
$36.59 M
|
| Weighted Average Shares Out Diluted |
$59.20 M
|
$52.64 M
|
$36.73 M
|
$36.59 M
|
$36.59 M
|
$36.59 M
|
| Link |
|
|
|
|
|
|
